Kapadia Sandip

CHIEF FINANCIAL OFFICER at HRMY; Director at PASG; CFO and Treasurer at INTERCEPT PHARMACEUTICALS INC

Sold, on record
$4.2M
Dollars the filings state
Form 4 sales
13
Latest Jan 26, 2026
Form 144 notices
0
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

3
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale HRMYRoutine
    Jan 21 2025

    Sold 25,000 shares at $40.18 ($1M)

    Kapadia Sandip, CHIEF FINANCIAL OFFICER

    10b5-1 planSold 100% of holdings ($1M position)0 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale HRMYRoutine
    Jan 27 +6 days

    Sold 1,775 shares at $38.05 ($68k)

    Kapadia Sandip, CHIEF FINANCIAL OFFICER

    10b5-1 planSold 100% of holdings ($68k position)0 shares leftFiling

  3. 3 Form 4 sale HRMYRoutine
    Apr 1 +64 days

    Sold 6,987 shares at $32.55 ($227k)

    Kapadia Sandip, CHIEF FINANCIAL OFFICER

    10b5-1 planSold 100% of holdings ($227k position)0 shares leftFiling

  4. 4 Form 4 sale HRMYUnusual
    Aug 15 +136 days

    Sold 21,573 shares at $36.50 ($787k)

    Kapadia Sandip, CHIEF FINANCIAL OFFICER

    10b5-1 planSold 100% of holdings ($787k position)0 shares left3.1x usual sizeFiling

  5. 5 Form 4 sale HRMYRoutine
    Nov 21 +98 days

    Sold 3,427 shares at $35.00 ($120k)

    Kapadia Sandip, CHIEF FINANCIAL OFFICER

    10b5-1 planSold 100% of holdings ($120k position)0 shares left0.2x usual sizeFiling

  6. 6 Form 4 sale HRMYRoutine
    Dec 5 +14 days

    Sold 20,000 shares at $39.54 ($791k)

    Kapadia Sandip, CHIEF FINANCIAL OFFICER

    10b5-1 planSold 100% of holdings ($791k position)0 shares left2.9x usual sizeFiling

  7. 7 Form 4 sale HRMYRoutine
    Jan 15 +41 days

    Sold 20,961 shares at $35.92 ($753k)

    Kapadia Sandip, CHIEF FINANCIAL OFFICER

    10b5-1 planSold 100% of holdings ($753k position)0 shares left1.6x usual sizeFiling

  8. 8 Form 4 sale HRMYRoutine
    Jan 26 +11 days

    Sold 3,746 shares at $37.15 ($139k)

    Kapadia Sandip, CHIEF FINANCIAL OFFICER

    10b5-1 planSold 13.3% of holdings ($1.1M position)24,521 shares left0.2x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (13)

Form 144 notices and Form 4 sales by Kapadia Sandip
Source
Jan 26, 2026HRMYCHIEF FINANCIAL OFFICERForm 4 sale3,746$139k13.3%RoutineSEC
Jan 15, 2026HRMYCHIEF FINANCIAL OFFICERForm 4 sale20,961$753k100.0%RoutineSEC
Dec 5, 2025HRMYCHIEF FINANCIAL OFFICERForm 4 sale20,000$791k100.0%RoutineSEC
Nov 21, 2025HRMYCHIEF FINANCIAL OFFICERForm 4 sale3,427$120k100.0%RoutineSEC
Aug 15, 2025HRMYCHIEF FINANCIAL OFFICERForm 4 sale21,573$787k100.0%UnusualSEC
Apr 1, 2025HRMYCHIEF FINANCIAL OFFICERForm 4 sale6,987$227k100.0%RoutineSEC
Jan 27, 2025HRMYCHIEF FINANCIAL OFFICERForm 4 sale1,775$68k100.0%RoutineSEC
Jan 21, 2025HRMYCHIEF FINANCIAL OFFICERForm 4 sale25,000$1M100.0%RoutineSEC
Dec 1, 2022PASGDirectorForm 4 sale5,000$6k100.0%UnusualSEC
Jan 5, 2021INTERCEPT PHARMACEUTICALS INCCFO and TreasurerForm 4 sale2,193$54k8.4%Plan not statedSEC
Dec 15, 2020INTERCEPT PHARMACEUTICALS INCCFO and TreasurerForm 4 sale1,763$58k6.1%Plan not statedSEC
Oct 2, 2017INTERCEPT PHARMACEUTICALS INCChief Financial OfficerForm 4 sale354$21k1.7%Plan not statedSEC
Jul 3, 2017INTERCEPT PHARMACEUTICALS INCChief Financial OfficerForm 4 sale1,431$174k6.5%Plan not statedSEC